statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology Astellas and Poseida Therapeutics Enter Into Research...

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting Poseida Therapeutics Announces Strong Lineup of Presentations at the...

Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements...

Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma Poseida Therapeutics...

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma

Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, April...

Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Poseida Therapeutics names Syed Rizvi, M.D., as Chief Medical Officer

Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer PR Newswire SAN DIEGO, March 25, 2024 SAN DIEGO...

Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer

Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference PR Newswire...

Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

This price move could indicate a change in the trend, and may be a sell signal for investors...

Poseida Therapeutics (PSTX, $3.22) price exceeded its 50-day Moving Average on March 14, 2024

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Volume	549,987.00
52-Wk High	$4.27
52-Wk Low	$1.54

PSTX Poseida Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals